miRNA identification by nuclease digestion in ELISA for diagnosis of osteosarcoma-Reference-Cited by-同舟云学术

miRNA identification by nuclease digestion in ELISA for diagnosis of osteosarcoma

Published:2021-06-15 Issue: Volume: Page:
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Lei Jie¹,He Meng‐Yin²,Li Jie³,Li Hao⁴,Wang Wei⁴,Gopinath Subash C.B.⁵⁶^ORCID,Xu Liang‐Zhou²^ORCID

Affiliation:

1. College of Acupuncture and Orthopedics Hubei University of Chinese Medicine Wuhan Hubei China

2. Department of Radiology Wuhan Hospital Of Traditional Chinese Medicine Wuhan Hubei China

3. Department of Orthopedics First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine Guangzhou Guangdong China

4. First Clinical Medical College of Hubei University of Traditional Chinese Medicine Wuhan Hubei China

5. Institute of Nano Electronic Engineering Universiti Malaysia Perlis (UniMAP) Kangar Perlis 01000 Malaysia

6. Faculty of Chemical Engineering Technology Universiti Malaysia Perlis (UniMAP) Arau Perlis 02600 Malaysia

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bab.2209

Reference26 articles.

1. Osteopontin as a biomarker for osteosarcoma therapy and prognosis;Han X;Oncol Lett,2019

2. Detection of femtomolar level osteosarcoma‐related gene via a chronocoulometric DNA biosensor based on nanostructure gold electrode;Zhong G;Int J Nanomedicine,2012

3. Molecular mechanisms and microRNAs in osteosarcoma pathogenesis;Kushlinskii NE;Biochemistry (Mosc),2016

4. Ultrasensitive fluorescent miRNA biosensor based on a “sandwich” oligonucleotide hybridization and fluorescence resonance energy transfer process using an Ln(III)‐MOF and Ag nanoparticles for early cancer diagnosis: application of central composite design;Afzalinia A;ACS Appl Mater Interfaces,2020

5. Involvement and clinical aspects of microRNA in osteosarcoma;Kumar RMR;Int J Mol Sci,2016